Technical Note
Protocol
Product Sheet
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Blueprint Genetics evaluates Twist Custom Panels for hereditary disease | AGBT 2019
Dr. Pertteli Salmenperä of Blueprint Genetics details the importance of coverage uniformity in NGS testing of hereditary disorders
Covered in this Webinar
Learn about the importance of quality sequencing in clinical adoption of NGS for Rare Disease testing.
Learn about the process of building an optimizing a targeted clinical panel for Rare Disease Testing.
Hear how Twist Target Enrichment Panels can be designed, tested and optimized for exceptional performance.
Dr. Salmenperä discusses the importance of sequencing quality and consistency when driving adoption of Next Generation Sequencing approaches in a clinical setting.
Share your details to Watch the Webinar
